Search Results - michael+kornberg

2 Results

Sort By:

Indole Lactate for the Treatment of Multiple Sclerosis

Unmet Need2.8 million people are estimated to be living with multiple sclerosis (MS) worldwide (35.9 per 100,000 population) (Walton et al.). The gold standard of care consists of symptom relieving remedies as well as disease modifying therapies. However, there are no curative therapies for MS, and most existing disease modifying therapies are only...

Published: 3/14/2025 | Inventor(s): Pavan Bhargava, Peter Calabresi, Michael Kornberg, Kathryn Fitzgerald

Keywords(s):

Category(s): Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations, Clinical and Disease Specializations > Neurology > Multiple Sclerosis

Novel Therapeutic Drug for Multiple Sclerosis

INVENTION NOVELTY This molecule, through its action on a unique target that is different from current therapeutic treatments for MS, has both immunosuppressive and neuromodulatory properties that will better prevent the progression of MS and repair the neuronal damage caused by the immune cells in MS. Currently, there are no MS drugs in the market...

Published: 3/13/2025 | Inventor(s): Paul Kim, Michael Kornberg, Peter Calabresi, Solomon Snyder

Keywords(s): Chronic Inflammatory Diseases, CNS and Neurological Disorders, Disease Indication, Multiple Sclerosis, Multiple Sclerosis (MS), Neurodegeneration, Novel, Predicted Novelty, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics